Metronomic cyclophosphamide in elderly patients with advanced, castration-resistant prostate cancer.
Fontana
Andrea
A
Bocci
Guido
G
Galli
Luca
L
D'Arcangelo
Manolo
M
Derosa
Lisa
L
Fioravanti
Anna
A
Orlandi
Paola
P
Barletta
Maria Teresa
MT
Landi
Lorenza
L
Bursi
Simona
S
Minuti
Gabriele
G
Bona
Eleonora
E
Grazzini
Ilaria
I
Danesi
Romano
R
Falcone
Alfredo
A
D000368:Aged; D000369:Aged, 80 and over; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage*; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D000068579:Celecoxib; D052246:Cyclooxygenase 2 Inhibitors / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage*; D003907:Dexamethasone / Q000008:administration & dosage; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D011720:Pyrazoles / Q000008:administration & dosage; D012189:Retrospective Studies; D013449:Sulfonamides / Q000008:administration & dosage
D018906:Antineoplastic Agents, Alkylating; D018931:Antineoplastic Agents, Hormonal; D052246:Cyclooxygenase 2 Inhibitors; D011720:Pyrazoles; D013449:Sulfonamides; D003907:Dexamethasone; D003520:Cyclophosphamide; D000068579:Celecoxib